CareLit · DOI-Nachweis · Aktuelle Ernährungsmedizin
COMPATIBILITY AND STABILITY ASSESSMENT OF SANDIMMUN® IN COMMERCIAL ALL-IN-ONE PARENTERAL NUTRITION ADMIXTURES: CHALLENGES FOR THE VALIDATION OF THE METHODS
DOI 10.1055/s-0037-1603294
Bibliografische Angaben
Nachweis in CareLit
Autor:innenAubry, E.; Bilang, N.; Aeberhard, C.; Mühlebach, S.; Stanga, Z.
ZeitschriftAktuelle Ernährungsmedizin
Ausgabe3/2017
Jahrgang / SeitenJg. 19 · S. 1 bis 1
Kernaussage aus der Literatur
Abstract-Vorschau
Introduction: Patients with parenteral nutrition (PN) often require i.v. drugs to treat underlying diseases. Critical dose drug cyclosporine A (CsA; Sandimmun®) is used in transplanted patients potentially also candidates for PN. CsA is a highly lipophilic drug solubilized for the i.v. formulation. All-in-one (AIO) PN are complex admixtures with numerous potential interactions asking for critical evaluation of treat…
Zitieren
Zitierempfehlung
Aubry, E.; Bilang, N.; Aeberhard, C.; Mühlebach, S.; Stanga, Z (2017) COMPATIBILITY AND STABILITY ASSESSMENT OF SANDIMMUN® IN COMMERCIAL ALL-IN-ONE PARENTERAL NUTRITION ADMIXTURES: CHALLENGES FOR THE VALIDATION OF THE METHODS. Aktuelle Ernährungsmedizin, 19 (3), 1 bis 1. https://doi.org/10.1055/s-0037-1603294
Mit CareLit weiterarbeiten